In an astonishing statement from the FDA, they acknowledged that since “Psychiatric Effects” will specifically be identified within the “Central Nervous System Effects” subheading, psychiatric adverse events are automatically assumed to be part of the existing Black Box warning.
Adverse events added by the FDA are some of those requested by Dr. Bennett previously.
The FDA is strengthening the current warnings in the prescribing information that the fluoroquinolone antibiotics may cause significant decreases in blood sugar and certain mental health side effects.
Pharmaceutical companies hide, ignore, or misrepresent evidence about new drugs; distort the medical literature; and misrepresent products to prescribing physicians.
Drug’s that can mutate DNA and create a disease process are downright scary. They start the ball rolling on a pathology that often appears later on..
It is promising that such a prestigious journal covered the controversy of the FQ's.
To those who are new to my plight or are unfamiliar with my personal situation, my life is delineated with a clear demarcation line. The life before taking Levaquin, a fluoroquinolone (FQ) antibiotic, and my life after. My healthy life before and my not so healthy life after. It is my story, my quin story, my life after Levaquin; Extremely healthy in one season, and a struggle with health the next.
After so many unremarkable tests, and so many years, some of the bigger pieces of the puzzle, for me, are starting to fall into place.
So the next time someone asks you 'Why are these drugs still on the market?" even though you may not agree, you will at least know the answer.
Fluoroquinolone Antibiotics are Chemotherapeutic agents in their method of action and adverse event profile.
Every once in a while I get the dubious honor of talking to a doctor who has been floxed. This conversation was a poignant example of dangerous the FQ's are in our society
Floxies are all poster children for peroxidation of cellular and mitochondrial lipids then subsequent damage to proteins and DNA.
One culprit that is often overlooked in chronic Fluoroquinolone toxicity is small intestinal bacterial overgrowth, or SIBO.
I believe that metabolomics is going to open a door for giving us insight into chronic fluoroquinolone toxicity and provide insight into treatment options for those chronically suffering.